This podcast series is sponsored in part by*
Hosted by
ABCs of NMOSD is an education podcast series to share knowledge about Neuromyelitis Optica Spectrum Disorder – NMOSD, a rare relapsing autoimmune disorder that preferentially causes inflammation in the optic nerves and spinal cord.
In collaboration with
NMOSD Education Podcast Series
ABCs of NMOSD brings together the latest information and research about all things NMOSD, from diagnosis and treatment to quality of life and what it’s like to live with NMOSD.
Throughout the series, we invite medical experts and researchers, to share the latest up-to-date research and clinical knowledge with us, answer questions about the diagnostic process, biomarkers, new therapies, relapses, and managing symptoms such as pain and fatigue. We will have conversations with individuals who have been diagnosed with NMOSD, their caregivers, and allied health professionals to learn from their experiences. Listeners will also learn about how to advocate for themselves at school and at work, learn where to find help and support, how to navigate health insurance, and how to work with a team of medical experts. We hope this series will positively impact those living with NMOSD and help our community be better self-advocates.
Alexion is a global biopharmaceutical company focused on serving patients with severe and rare disorders through the innovation, development and commercialization of life-transforming therapeutic products. Their goal is to deliver medical breakthroughs where none currently exist, and they are committed to ensuring that patient perspective and community engagement is always at the forefront of their work.
Amgen is focused on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. They apply scientific expertise and courage to bring clinically meaningful therapies to patients. Amgen believes science and compassion must work together to transform lives. For additional information about Amgen, please visit: https://www.amgen.com.
UCB innovates and delivers solutions that make real improvements for people living with severe diseases. We partner with and listen to patients, caregivers, and stakeholders across the healthcare system to identify promising innovations that create valuable health solutions.
* The Executive Committee of SRNA with the medical and scientific council determines the content and topics of the podcasts. Sponsors are not able to influence the education program.
